Catheter ablation of atrial fibrillation: -state of the art -

Circulation Journal

Volumn 75, Issue 10, 2011, Pages 2305-2311

  Kumagai, Koichiro ^a  

^a FUKUOKA SANNO HOSPITAL   (Japan)

Author keywords

Atrial fibrillation; Catheter ablation; Pulmonary veins

Indexed keywords

ANTIARRHYTHMIC AGENT;

BOX ISOLATION; CARDIOVASCULAR PROCEDURES; CATHETER ABLATION; CLINICAL EFFECTIVENESS; COMPLEX FRAGMENTED ATRIAL ELECTROGRAM; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROGRAPHY; EMBOLISM; ESOPHAGUS INJURY; GASTRIC DYSMOTILITY; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART INJURY; HEART PROARRHYTHMIA; HEART TAMPONADE; HOMONYMOUS HEMIANOPIA; HUMAN; LONG TERM CARE; MEDICAL TECHNOLOGY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS DRAINAGE; PERIPHERAL NERVE INJURY; PRIMARY HEALTH CARE; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY ABLATION; REVIEW; STROKE; TACHYCARDIA; TREATMENT INDICATION; VALVULAR HEART DISEASE;

ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; PULMONARY VEINS; TREATMENT OUTCOME;

EID: 80053064259     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0658     Document Type: Review

References (57)

1. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
2. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmaco-logical responses, and effects of radiofrequency ablation. Circulation 1999; 100: 1879-1886.
3. Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T, Deisenhofer I, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102: 2463-2465.
4. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000; 102: 2619-2628.
5. Hocini M, Jais P, Sanders P, Takahashi Y, Rotter M, Rostock T, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: A prospective randomized study. Circulation 2005; 112: 3688-3696.
6. Kumagai K, Muraoka S, Mitsutake C, Takashima H, Nakashima H. A new approach for complete isolation of the posterior left atrium including pulmonary veins for atrial fibrillation. J Cardiovasc Elecrophysiol 2007; 18: 1047-1052.
7. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43: 2054-2056.
8. Nakagawa H, Yokoyama K, Scherlag BJ, Katari V, Aoyama H, Foresti S, et al. Ablation of autonomic ganglia. In: Steinberg JS, Calkins H, Jais P, editors. A practical approach to catheter ablation of atrial fibrillation. 1st edn. Lippincott, Williams and Wilkins Publishing, 2008; 218-230.
9. Ito M, Yanaga T, Saeki K, Arita M, Ishihara M, Mashiba H. Studies on sino-caval conduction of the rabbit with microelectrodes. Jpn J Physiol 1964; 14: 439-449.
10. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000; 101: 194-199.
11. Skanes AC, Mandapati R, Berenfeld O, Davidenko JM, Jalife J. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 1998; 98: 1236-1248.
12. Arora R, Verheule S, Scott L, Navarrete A, Katari V, Wilson E, et al. Arrhythmogenic substrate of the pulmonary veins assessed by highresolution optical mapping. Circulation 2003; 107: 1816-1821.
13. Kumagai K, Ogawa M, Noguchi H, Yasuda T, Nakashima H, Saku K. Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. J Am Coll Cardiol 2004; 43: 2281-2289.
14. Oral H, Knight BP, Ozaydin M, Chugh A, Lai SW, Scharf C, et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: Feasibility and mechanistic insights. Circulation 2002; 106: 1256-1262.
15. Scharf C, Sneider M, Case I, Chugh A, Lai SW, Pelosi F Jr, et al. Anatomy of the pulmonary veins in patients with atrial fibrillation and effects of segmental ostial ablation analyzed by computed tomography. J Cardiovasc Electrophysiol 2003; 14: 150-155.
16. Dill T, Neumann T, Ekinci O, Breidenbach C, John A, Erdogan A, et al. Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrastenhanced three-dimensional magnetic resonance imaging. Circulation 2003; 107: 845-850.
17. Yamane T, Date T, Kanzaki Y, Inada K, Matsuo S, Shibayama K, et al. Segmental pulmonary vein antrum isolation using the "large-size" lasso catheter in patients with atrial fibrillation. Circ J 2007; 71: 753-760.
18. Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, et al. Complete isolation of left atrium surrounding the pulmonary veins: New insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 2004; 110: 2090-2096.
19. Verma A, Marrouche NF, Natale A. Pulmonary vein antrum isolation: Intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol 2004; 15: 1335-1340.
20. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and metaanalyses. Circ Arrhythm Electrophysiol 2009; 2: 349-361,
21. Verma A, Natale A, Padanilam BJ, Prystowsky EN. Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation 2005; 112: 1214-1222.
22. Kamino K. Optical approaches to ontogeny of electrical activity and related functional organization during early heart development. Physiol Rev 1991; 71: 53-91.
23. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable macroreentrant source as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000; 101: 194-199.
24. Lim WS, Tai CT, Hsieh MH, Tsai CF, Lin YK, Tsai HM, et al. Catheter ablation of paroxysmal atrial fibrillation initiated by nonpulmonary vein ectopy. Circulation 2003; 107: 3176-3183.
25. Marcids V, Schilling RJ, Ho SY, Chow AW, Davies DW, Peters NS. Characterization of left atrial activation in the intact human heart. Circulation 2003; 107: 733-739.
26. Todd DM, Skanes AC, Guiraudon G, Guiraudon C, Krahn AD, Yee R, et al. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: Electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 2003; 108: 3108-3114.
27. Sueda T, Nagata H, Rehash K, Morita S, Okada K, Sushi M, et al. Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve operations. Ann Thorac Surg 1997; 63: 1070-1075.
28. Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ. Rapid pulmonary vein isolation combined with autonomic ganglia modification: A randomized study. Heart Rhythm 2011; 8: 672-678.
29. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004; 109: 327-334.
30. Yamaguchi Y, Kumagai K, Nakashima H, Saku K. Long-term effects of box isolation on sympathovagal balance in atrial fibrillation. Circ J 2010; 74: 1096-1103.
31. Kumagai K, Nakashima H. Noncontact mapping-guided catheter ablation of atrial fibrillation. Circ J 2009; 73: 233-241.
32. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up: A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4: 816-861.
33. Haïssaguerre M, Sanders P, Hocini M, Hsu LF, Shah DC, Scavée C, et al. Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation 2004; 109: 3007-3013.
34. Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N, et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation 2007; 115: 2606-2612.
35. Haïssaguerre M, Sanders P, Hocini M, Takahashi Y, Rotter M, Sacher F, et al. Catheter ablation of long-lasting persistent atrial fibrillation: Critical structures for termination. J Cardiovasc Electrophysiol 2005; 16: 1125-1137.
36. Haïssaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, et al. Catheter ablation of long-lasting persistent atrial fibrillation: Clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005; 16: 1138-1147.
37. Nademanee K, Lockwood E, Oketani N, Gidney B. Catheter ablation of atrial fibrillation guided by complex fractionated atrial electrogram mapping of atrial fibrillation substrate. J Cardiol 2010; 55: 404-408.
38. Lemola K, Desjardins B, Sneider M, Case I, Chugh A, Good E, et al. Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm 2005; 2: 923-928.
39. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377.
40. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
41. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105.
42. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol 2009; 53: 1798-1803.
43. Chen MS, Marrouche NF, Khaykin Y, Gillinov AM, Wazni O, Martin DO, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 2004; 43: 1004-1009.
44. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383.
45. Khaykin Y, Marrouche NF, Saliba W, Schweikert R, Bash D, Chen MS, et al. Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm 2004; 1: 33-39.
46. Bhargava M, Marrouche NF, Martin DO, Schweikert RA, Saliba W, Saad EB, et al. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter. J Cardiovasc Electrophysiol 2004; 15: 8-13.
47. Khan MN, Jais P, Cummings J, Di Biase L, Sanders P, Martin DO, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008; 359: 1778-1785.
48. Callans DJ. Apples and oranges: Comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation. Circulation 2008; 118: 2488-2490.
49. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765.
50. Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008; 51: 843-849.
51. Themistoclakis S, Corrado A, Marchlinski FE, Jais P, Zado E, Rossillo A, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010; 55: 735-743.
52. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, SalibaW, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 2005; 293: 2634-2640.
53. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: The APAF Study. J Am Coll Cardiol 2006; 48: 2340-2347.
54. Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: A systematic review. Arch Intern Med 2008; 168: 581-586.
55. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008; 118: 2498-2505.
56. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, et al. Comparison of antiarrhythmic drug therapy and radiofre-quency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 2010; 303: 333-340.
57. nd AFNET-EHRA consensus conference 'Research perspectives in AF'. Eur Heart J 2009; 30: 2969-2977.